In 2006, a biotech company halted development of the peptide CJC 1295 after a healthy subject died of a heart attack during a phase two trial. Whether the compound caused the death was Fragment 176 191 & CJC 1295 & Ipamorelin 12MG Raw Amino CJC 1295 Ipamorelin Blend 5MG Research Peptide Combination Compounded peptides are being promoted and sold by wellness companies without adequate clinical evidence supporting their safety or efficacy. This presents an alarming safety concern, which ECRI and ISMP warned patients,